A61K 31 - Medicinal preparations containing organic active ingredients

Patents for A61K 31 - Medicinal preparations containing organic active ingredients (785,912)
08/1993
08/11/1993	EP0554829A2 Pyrazole derivatives with antiinflammatory, analgesic and antithrombolic activity
08/11/1993	EP0554794A1 Aminobenzoic acid derivatives
08/11/1993	EP0554708A1 Thioether conjugates
08/11/1993	EP0554543A2 1,2,4-Triaminobenzene derivatives and process for their preparation
08/11/1993	EP0554436A1 Gaba receptor modulators
08/11/1993	EP0554377A1 Aryl and heteroaryl compounds having anti-retrovirus activity
08/11/1993	EP0554364A1 Lipid a composition as immunogenic agents to prevent or treat gram-negative bacterial infections
08/11/1993	EP0554363A1 Alteration of rate and character of hair growth
08/11/1993	EP0554352A1 A method for transplanting cells into the brain and therapeutic uses therefor
08/11/1993	EP0554319A1 Antimicrobial composition
08/11/1993	EP0554291A1 Treatment of non-inflammatory and non-infectious bowel disorders
08/11/1993	EP0554274A1 Nucleoside derivatives
08/11/1993	EP0554247A1 Neuroprotective indolone and related derivatives
08/11/1993	EP0531447A4 Compositions and methods for modulating rna activity through modification of the 5' cap structure of rna
08/11/1993	EP0507870A4 Polyhemoglobin stabilized by purine derivatives and glutathione
08/11/1993	EP0478686B1 Fluorine and phosphorous-containing amphiphilic molecules with surfactant properties
08/11/1993	EP0447491B1 Protoporphyrinogen inhibitors and their use in compositions for detecting and treating tumours
08/11/1993	EP0406327B1 Long lasting composition of propafenone and quinidine for treatment of cardiac conditions
08/11/1993	EP0396620B1 Aminomethyl-chroman and -thiochroman compounds
08/11/1993	EP0382779B1 Tocopherol-based pharmaceutical systems
08/11/1993	EP0346465B1 1-carboxy-1-vyniloxyiminoaminothiazole cephalosporing derivatives and process for their preparation
08/11/1993	EP0334967B1 Keratosis-treating agent
08/11/1993	CN1075166A Process for preparing optically active cyanohydrins with enzymes
08/11/1993	CN1075146A Process for making antimicrobial quinolonyl lactams
08/11/1993	CN1075145A Aminobenzoic acid derivatives
08/11/1993	CN1075141A Specific 1,4-dihydropyridine-3,5-dicarboxylic acid ester, process for its preparation and its pharmaceutical use
08/11/1993	CN1075081A Preparing method of colloid anaesthetic compound
08/11/1993	CN1075080A Zn-Ca oral liquid and its preparing method
08/11/1993	CN1075079A Medicaments
08/11/1993	CN1075078A Medicaments
08/11/1993	CA2088744A1 Method for treating cancer using a tyrosine protein kinase inhibitor
08/11/1993	CA2079267A1 Amidinonaphthyl furancarboxylate derivatives and acid addition salts thereof
08/10/1993	US5235076 Anticarcinogenic agents
08/10/1993	US5235073 Polyethoxylated vitamin e
08/10/1993	US5235072 2-oxabicyclo(2,2,1)heptane derivatives and pharmaceutical
08/10/1993	US5235065 Process for the preparation of a d-(+)-biotin intermediate
08/10/1993	US5235055 Antipsychotic quinoline derivatives of benzodioxanmethylamine
08/10/1993	US5235054 3-carboxaldehyde substituted quinolines and naphthyridines
08/10/1993	US5234957 Compositions and methods for topical administration of pharmaceutically active agents
08/10/1993	US5234956 Reducing increase in calcium ion concenration; administering nitroglycerin, nitroprusside or derivatives thereof; treating AIDS, Alzheimer's, CNS disorders, cardiovascular disorders
08/10/1993	US5234955 Antitumor compositions and methods of treatment
08/10/1993	US5234954 Treatment of hyperlipidemia with 15-keto-prostaglandin compounds
08/10/1993	US5234953 9-Deoxy-2'9-methano-3-oxa-4,5,6-trinor-3,7'-(1'3-inter-phenylene) -13,14-dihydroprostaglandin F1; vasodilation
08/10/1993	US5234952 Anticoagulants
08/10/1993	US5234949 Treatment of arrhythmias
08/10/1993	US5234947 Potassium channel activating compounds and methods of use thereof
08/10/1993	US5234945 Method of producing body weight and food intake using a dopamine D2 receptor agonist
08/10/1993	US5234940 Photochemotherapeutic method using 5-aminolevulinic acid and precursors thereof
08/10/1993	US5234936 Pyrimidocycloalkanes as a ii antagonists
08/10/1993	US5234935 Preventing myocardial infarct
08/10/1993	US5234932 Bronchodilators, antiallergens, antiinflammatory agents
08/10/1993	US5234930 Pyrazolopyridine compounds which have useful pharmaceutical utility
08/10/1993	US5234929 Method of treating motion sickness with anticonvulsants and antitussive agents
08/10/1993	US5234928 Quinazoline-3-alkanoic acid derivatives, their salts and their preparation processes
08/10/1993	US5234927 Magnesium oxide as a biodegradation retarding agent
08/10/1993	US5234923 Hypotensive agents
08/10/1993	US5234922 Administering cystic fibrosis transmembrane conductance regulator chloride channel blocker or potassium channel opener
08/10/1993	US5234914 Methods of treating hemorrhoids and anorecial disease
08/10/1993	US5234913 Antiviral nucleoside combination
08/10/1993	US5234906 Hyperglycemic compositions
08/10/1993	US5234904 For food and drinks
08/10/1993	US5234698 Intraprostatic injection of zinc ions for treatment of inflammatory conditions and benign and malignant tumors of the prostate
08/10/1993	US5234697 Compositions of gastric acid-resistant microspheres containing salts of bile acids
08/10/1993	US5234695 Water dispersible vitamin E composition
08/10/1993	US5234691 Encapsulated for oral administration
08/10/1993	US5234683 Ethyleneoxide-propylene oxide copolymer causing the thalmus to increrase in size
08/10/1993	US5234635 Dissolving lipid in water immiscible organic solvent, adding to aqueous phase, dispersing with high speed rotating stirrer, evaporating solvent
08/10/1993	US5234634 Method for preparing alpha-tocopherol vesicles
08/10/1993	US5234405 Brain resuscitation device and method for performing the same
08/10/1993	US5234404 Diagnosis, evaluation and treatment of coronary artery disease by exercise simulation using closed loop drug delivery of an exercise simulating agent beta agonist
08/10/1993	US5233995 Encapsulated particles useful as contrast agents in ultrasound and x-ray imaging compositions and methods
08/10/1993	CA2042053C Lipid a monosaccharide analogues
08/10/1993	CA1321204C Acylation products of bis(2-imidazolin-2- ylhydrazones) of 9,10-anthracenedicarboxaldehyde
08/10/1993	CA1321199C Chloroaniline derivatives
08/10/1993	CA1321198C Heterocycle-substituted diphosphonate compounds, pharmaceutical compositions, and methods of treating abnormal calcium and phosphate
08/10/1993	CA1321197C 2,3-dihydro-1h-phenalene-2-amino compounds as anti-psychotic drugs
08/10/1993	CA1321196C Antiviral tricyclic benzocyclopyrimidine derivatives
08/10/1993	CA1321195C Substituted benzazepines, their preparation and pharmaceutical compositions containing them
08/10/1993	CA1321194C Benzazepine and benzazepinone derivatives
08/10/1993	CA1321146C Enkephalinase and endorphinase inhibitors as anti-craving compositions
08/10/1993	CA1321145C Pharmaceutical preparations
08/10/1993	CA1321144C Pharmaceutical preparations
08/10/1993	CA1321141C Biologically active agent from human breast cyst fluid
08/08/1993	WO1993015729A1 Side-effect alleviant
08/08/1993	CA2107581A1 Side-effect alleviant
08/08/1993	CA2088864A1 Oxime derivatives
08/07/1993	WO1994016563A1 1,2-dithiole-3-thiones for the treatment of reverse transcriptase-dependent viral infections
08/06/1993	CA2129526A1 Novel amidine derivatives, their preparation and their use as medicaments with ltb4 antagonistic effect
08/06/1993	CA2088836A1 1,4-dihydropyridine compounds, processes for preparation thereof and pharmaceutical compositions comprising the same
08/06/1993	CA2088835A1 Pyrazole derivatives, processes for preparation thereof and pharmaceutical composition comprising the same
08/06/1993	CA2088719A1 Antitumor compositions and methods of treatment
08/05/1993	WO1993015207A2 Hepatitis therapeutics
08/05/1993	WO1993015205A2 Synthetic haemophilus influenzae conjugate vaccine
08/05/1993	WO1993015194A1 Enhancement of ribozyme catalytic activity by a neighboring facilitator oligonucleotide
08/05/1993	WO1993015187A1 Nucleozymes
08/05/1993	WO1993015112A2 COMPOUNDS AND METHODS FOR INHIBITING β-PROTEIN FUNCTION
08/05/1993	WO1993015103A2 Novel steroid intermediates and processes for their preparation
08/05/1993	WO1993015099A1 Antiparasitic agents
08/05/1993	WO1993015085A1 2-isocephem and oxacephem derivatives, processes for their preparation, intermediates thereof and use as antibacterial agents
08/05/1993	WO1993015084A1 Novel cephalosporin compounds

1 ... 7173 7174 7175 7176 7177 7178 7179 7180 7181 7182 7183 7184 7185 7186 7187 7188 7189 7190 7191 7192 7193 ... 7860